The effect of granulocyte colony stimulating factor in patients with leukopenia due to sepsis.
The use of granulocyte stimulating factor (G-CSF) (Neupogen, Amgen Inc., Thousand Oaks, Calif.) has become acceptable for treating both primary and acquired leukopenia. Leukopenia associated with infection is an ominous sign of overwhelming sepsis. In this article, we present two cases of infection that were related to leukopenia which were successfully treated with G-CSF.
Bittner
E W
EW
Ruby Memorial Hospital, Morgantown, USA.
Hartzog
J M
JM
Chendrasekhar
A
A
D000368:Aged; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D018805:Sepsis / Q000150:complications*
D016179:Granulocyte Colony-Stimulating Factor